Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Baseline: mean weight 106.4 kg (234.6 lb), mean BMI 38.2, mean A1C 7.7%
a Phase III study compared the two products in RA not sufficiently controlled by methotrexate in order to establish equivalent efficacy and comparable pharmacokinetic, safety and immunogenicity profiles
Individual Metabolism and Health Status Metabolic rates vary among individuals due to factors such as genetics, age, gender, and underlying health conditions
Duration of Study: A short-term acute study will likely employ a different KLOW dosage guide than a long-term chronic investigation
Synonym GLP-1 (7-37) peptide
US$ 28.67
US$ 20.43
US$ 25.71
US$ 23.77
US$ 20.47
US$ 28.57
